Access Bio,'Surge' in US Approval of Corona 19 Antigen Diagnosis Kit
This new looks very positive to me : ) . just waiting on the approval of CareStart COVID-19 IgM/IgG. lolAccessbio surged as it obtained emergency use approval (EUA) from the US Food and Drug Administration (FDA) for a rapid diagnosis kit for the novel coronavirus infection (Corona 19) antigen.
As of 9:15 am on the 12th, Access Bio in the KOSDAQ market is trading at 34,000 won, up 25.69% (6,950 won) compared to the previous trading day.
On the 10th, Accessbio announced on the 10th that its Corona 19 antigen rapid diagnosis kit'CareStart™ COVID-19 Antigen' has obtained emergency approval from the US FDA. This kit is a product that can quickly diagnose the presence of corona infection within 10 to 15 minutes by collecting a patient's sample from the nasopharynx and immunochromatography.
Media Update, page-6
Add AT1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
-0.001(5.00%) |
Mkt cap ! $12.14M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.0¢ | 1.9¢ | $4.355K | 222.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 1968855 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 416397 | 3 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| AT1 (ASX) Chart |